Does LAPATINIB DITOSYLATE Cause Investigation? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Investigation have been filed in association with LAPATINIB DITOSYLATE (Lapatinib). This represents 0.1% of all adverse event reports for LAPATINIB DITOSYLATE.
5
Reports of Investigation with LAPATINIB DITOSYLATE
0.1%
of all LAPATINIB DITOSYLATE reports
2
Deaths
4
Hospitalizations
How Dangerous Is Investigation From LAPATINIB DITOSYLATE?
Of the 5 reports, 2 (40.0%) resulted in death, 4 (80.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.
Is Investigation Listed in the Official Label?
Yes, Investigation is listed as a known adverse reaction in the official FDA drug label for LAPATINIB DITOSYLATE.
What Other Side Effects Does LAPATINIB DITOSYLATE Cause?
Diarrhoea (893)
Death (665)
Nausea (317)
Fatigue (301)
Vomiting (259)
Rash (249)
Drug ineffective (183)
Malignant neoplasm progression (183)
Off label use (141)
Disease progression (137)
What Other Drugs Cause Investigation?
ARANESP (403)
NEULASTA (371)
XGEVA (115)
FLUTICASONE\SALMETEROL (96)
DARBEPOETIN ALFA (86)
ADVAIR (77)
DENOSUMAB (65)
ADVAIR HFA (51)
ALBUTEROL (51)
VENTOLIN (47)
Which LAPATINIB DITOSYLATE Alternatives Have Lower Investigation Risk?
LAPATINIB DITOSYLATE vs LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN
LAPATINIB DITOSYLATE vs LARONIDASE
LAPATINIB DITOSYLATE vs LAROTRECTINIB
LAPATINIB DITOSYLATE vs LASILIX
LAPATINIB DITOSYLATE vs LASIX